Sandoz, a key producer of generics and biosimilars, announced that it has signed an agreement to acquire US biosimilar ranibizumab CIMERLI (ranibizumab-eqrn) from Coherus BioSciences, Inc. For $170 million in cash. According to the company’s...
The Ram Mandir Prathistha or consecration ceremony will begin in Ayodhya between 12:05 PM and 1:00 PM with Prime Minister Narendra Modi presiding over the ceremony. Prime Minister Narendra Modi is set to participate in...
Indian Immunologicals Ltd (IIL), a wholly owned subsidiary of the National Dairy Development Board (NDDB) and a biopharmaceutical company, has launched India's first hepatitis A vaccine 'Havisure'. This vaccine is a major step forward in the fight...
The Department of Pharmaceuticals has proposed to provide financial support to Micro, Small and Medium Enterprises (MSME) to help them upgrade their equipment to ensure better quality of medicines. "Under a central scheme, which is called...
The European Medicines Agency (EMA) has approved Synendos Therapeutics AG (Synendos), a global leader in cutting-edge Endocannabinoid System (ECS) treatments, to begin the phase 1 "first-in-human" clinical trial of its lead asset, SYT-510, a...
Amplia Therapeutics Limited reported that the US FDA has approved Amplia's IND application for a pancreatic cancer trial using their best-in-class focal adhesion kinase (FAK) inhibitor, narmafotinib. The proposed trial will investigate the safety...
DiagnaMed Holdings Corp announced the pilot launch of Cervai, a world-first consumer brain health and wellness AI solution that aims to 'raise a red flag' for potential brain health issues by estimating brain age and providing a brain health score...
The Union Cabinet has adopted separate memoranda with Ecuador, the Dominican Republic, and the Netherlands regarding cooperation in the area of medicinal product regulation. The three Memorandums of Understanding (MoU) signed by the Central Drugs...
Takeda announced that Hyqvia [Immune Globulin Infusion 10% (Human) with Recombinant Human Hyaluronidase] has been approved by the US Food and Drug Administration (FDA) for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP)...
Vertex Pharmaceuticals Incorporated has announced that Casgevy, a CRISPR/Cas9 gene-edited cell therapy, has been approved by the US Food and Drug Administration (FDA) for the treatment of transfusion-dependent beta thalassemia (TDT) in patients...
, CDSCO.jpg)
